CAS: 86197-47-9 - Dopexamine
Formula:C22H32N2O2
InChI:InChI=1S/C22H32N2O2/c25-21-11-10-20(18-22(21)26)13-17-24-15-7-2-1-6-14-23-16-12-19-8-4-3-5-9-19/h3-5,8-11,18,23-26H,1-2,6-7,12-17H2
InChI key:InChIKey=RYBJORHCUPVNMB-UHFFFAOYSA-N
SMILES:OC1=CC=C(C=C1O)CCNCCCCCCNCCC=2C=CC=CC2
- Synonyms:
- 1,2-Benzenediol, 4-[2-[[6-[(2-Phenylethyl)Amino]Hexyl]Amino]Ethyl]-
- 4-[2-({6-[(2-Phenylethyl)amino]hexyl}amino)ethyl]benzene-1,2-diol
- 4-[2-[[6-(Phenethylamino)hexyl]amino]ethyl]pyrocatechol
- 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]-1,2-benzenediol
- 86197-47-9
- Fpl 60278
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
DOPEXAMINE REF: IN-DA00H0EMCAS: 86197-47-9 | 99% | To inquire | Tue 26 Nov 24 | |
Dopexamine REF: 7W-GP2187CAS: 86197-47-9 | - - - | To inquire | Wed 27 Nov 24 | |
DOPEXAMINE REF: TM-T8653CAS: 86197-47-9 | 99.42% | 128.00 €~1,319.00 € | Tue 03 Dec 24 | |
Dopexamine REF: 3D-LDA19747CAS: 86197-47-9 | Min. 95% | To inquire | Tue 07 Jan 25 |
Ref: IN-DA00H0EM
1mg | 245.00 € | ||
2mg | 491.00 € | ||
5mg | 521.00 € | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 7W-GP2187
Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
DOPEXAMINE
CAS:86197-47-9
Dopexamine is a dopaminergic agonist
Formula:
C22H32N2O2
Purity:
99.42%
Color and Shape:
Solid
Molecular weight:
356.5
Ref: TM-T8653
1mg | 128.00 € | ||
2mg | 184.00 € | ||
5mg | 277.00 € | ||
10mg | 421.00 € | ||
25mg | 697.00 € | ||
50mg | 975.00 € | ||
100mg | 1,319.00 € | ||
1mL*10mM (DMSO) | 305.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Dopexamine
CAS:86197-47-9
Dopexamine is an inhibitor of the enzyme adenosine deaminase (ADA), which converts adenosine to inosine. …
Formula:
C22H32N2O2
Purity:
Min. 95%
Molecular weight:
356.5 g/mol
Ref: 3D-LDA19747
1mg | To inquire | ||
10mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025